Cohorts united against COVID-19 variants of concern

Last updated: 16.7.2025
Grant

The 'Cohorts united against COVID-19 variants of concern' program, under Horizon Europe, aimed to foster global collaboration in establishing and leveraging large-scale COVID-19 cohorts. This initiative sought to advance knowledge on SARS-CoV-2 variants, optimize clinical management, and bolster international pandemic preparedness through evidence-based research and data sharing.

Who is Funded for COVID-19 Variant Research

This section outlines who was eligible to receive funding, detailing the types of entities, the geographical scope, and the strategic objectives aimed at combating COVID-19 variants and enhancing global health security.

What is Funded for COVID-19 Research

This section details the types of projects, thematic areas, and activities that were supported, along with information on eligible costs and the typical developmental stage of funded initiatives under this important COVID-19 research program.

Type and Scope of Funding for COVID-19 Cohorts

This section outlines the financial details of the funding program, including the type of support offered, the expected funding amounts per project, and the typical duration for funded initiatives.

Conditions and Requirements for COVID-19 Research Funding

This section details the essential rules and specific conditions that applicants and beneficiaries needed to adhere to for the 'Cohorts united against COVID-19 variants of concern' program. It covers application terms, collaboration guidelines, data management, and ethical considerations.

Application Procedure for COVID-19 Funding

This section provides an overview of the application and selection process for the 'Cohorts united against COVID-19 variants of concern' program, detailing how proposals were submitted and evaluated.

This section identifies the foundational legal and official documents that governed the 'Cohorts united against COVID-19 variants of concern' funding program, ensuring transparency and adherence to European Union regulations.

Similar Programs

#COVID-19 variants#Horizon Europe funding#pandemic preparedness#cohort studies#public health#SARS-CoV-2 research#clinical management#vaccine effectiveness#infectious diseases#data sharing#EU grants#research and innovation#global health#health policy#epidemiology#clinical trials#health research

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

10,000,000 EUR

Allocated Budget

Allocated Budget:

30,000,000 EUR

Open Until

Open Until:

Ongoing

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

Worldwide, including EU Member States and specifically listed associated and third countries. Collaboration with regional public health and regulatory authorities across different world regions is encouraged.

Sectors

Sectors:

Healthcare, Medical Technology, Research and Development

Beneficiaries

Beneficiaries:

Research organisations, healthcare providers, public health authorities, universities

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Basic Research, Applied Research, Experimental Development, Pilot Testing, Implementation, Monitoring

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

Managed By:

Unknown

Additional Partners:

EU-funded projects ORCHESTRA, RECODID, EU COVID-19 data portal; other national, regional, and international initiatives; regional public health and regulatory authorities

0 x 0
XS